Journal Information

Statistics

Follow this link to access the full text of the article

Review
Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis
Nemolizumab: un innovador tratamiento biológico para el control de la interleuquina 31 (IL-31) clave en la dermatitis atópica y el prurigo nodular
E. Serra-Baldricha,
Corresponding author
ESerra@santpau.cat

Corresponding author.
, L.F. Santamaria-Babíb, J. Francisco Silvestrec
a Servicio de Dermatología, Hospital Sant Pau, Universidad Autónoma de Barcelona, Spain
b Catedrático de Inmunología Clínica y Traslacional, Head of translational Immunology Group, PCB, University of Barcelona, Spain
c Servicio de Dermatología, Hospital General de Alicante, Spain
Read
8513
Times
was read the article
2129
Total PDF
6384
Total HTML
Share statistics
Article information
ISSN: 00017310
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 214 83 297
2024 October 222 83 305
2024 September 207 89 296
2024 August 207 168 375
2024 July 197 108 305
2024 June 177 78 255
2024 May 172 64 236
2024 April 120 54 174
2024 March 136 55 191
2024 February 162 53 215
2024 January 209 71 280
2023 December 209 73 282
2023 November 274 63 337
2023 October 332 50 382
2023 September 894 53 947
2023 August 190 42 232
2023 July 203 71 274
2023 June 203 39 242
2023 May 233 58 291
2023 April 159 54 213
2023 March 179 40 219
2023 February 166 59 225
2023 January 152 90 242
2022 December 144 74 218
2022 November 149 97 246
2022 October 168 61 229
2022 September 187 58 245
2022 August 183 83 266
2022 July 231 87 318
2022 June 105 71 176
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?